当前位置: X-MOL 学术Redox Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis
Redox Biology ( IF 10.7 ) Pub Date : 2022-06-24 , DOI: 10.1016/j.redox.2022.102378
Ruimin Sun 1 , Xinyao Tian 2 , Yang Li 3 , Yan Zhao 4 , Zhecheng Wang 4 , Yan Hu 4 , Lijun Zhang 4 , Yue Wang 4 , Dongyan Gao 4 , Shusen Zheng 2 , Jihong Yao 4
Affiliation  

Peroxiredoxin 3 (PRDX3) acts as a master regulator of mitochondrial oxidative stress and exerts hepatoprotective effects, but the role of PRDX3 in liver fibrosis is not well understood. N6-methyladenosine (m6A) is considered the most prevalent posttranscriptional modification of mRNA. This study aimed to elucidate the effect of PRDX3 on liver fibrosis and the potential mechanism through which the m6A modification regulates PRDX3. PRDX3 expression was found to be negatively correlated with liver fibrosis in both animal models and clinical specimens from patients. We performed adeno-associated virus 9 (AAV9)-PRDX3 knockdown and AAV9-PRDX3 HSC-specific overexpression in mice to clarify the role of PRDX3 in liver fibrosis. PRDX3 silencing exacerbated hepatic fibrogenesis and hepatic stellate cell (HSC) activation, whereas HSC-specific PRDX3 overexpression attenuated liver fibrosis. Mechanistically, PRDX3 suppressed HSC activation at least partially via the mitochondrial reactive oxygen species (ROS)/TGF-β1/Smad2/3 pathway. Furthermore, PRDX3 mRNA was modified by m6A and interacted with the m6A readers YTH domain family proteins 1–3 (YTHDF1-3), as evidenced by RNA pull-down/mass spectrometry. More importantly, PRDX3 expression was suppressed when YTHDF3, but not YTHDF1/2, was knocked down. Moreover, PRDX3 translation was directly regulated by YTHDF3 in an m6A-dependent manner and thereby affected its function in liver fibrosis. Collectively, the results indicate that PRDX3 is a crucial regulator of liver fibrosis and that targeting the YTHDF3/PRDX3 axis in HSCs may be a promising therapeutic approach for liver fibrosis.



中文翻译:

m6A 阅读器 YTHDF3 介导的 PRDX3 翻译可减轻肝纤维化

Peroxiredoxin 3 (PRDX3) 作为线粒体氧化应激的主要调节剂并发挥保肝作用,但 PRDX3 在肝纤维化中的作用尚不清楚。氮6-甲基腺苷(m6A)被认为是最普遍的mRNA转录后修饰。本研究旨在阐明 PRDX3 对肝纤维化的影响以及 m6A 修饰调节 PRDX3 的潜在机制。在动物模型和患者临床标本中发现 PRDX3 表达与肝纤维化呈负相关。我们在小鼠中进行了腺相关病毒 9 (AAV9)-PRDX3 敲低和 AAV9-PRDX3 HSC 特异性过表达,以阐明 PRDX3 在肝纤维化中的作用。PRDX3 沉默加剧了肝纤维化和肝星状细胞 (HSC) 活化,而 HSC 特异性 PRDX3 过表达减弱了肝纤维化。从机制上讲,PRDX3 至少部分通过线粒体活性氧 (ROS)/TGF-β1/Smad2/3 通路抑制 HSC 活化。此外,PRDX3 mRNA 被 m6A 修饰并与 m6A 阅读器 YTH 域家族蛋白 1-3 (YTHDF1-3) 相互作用,如 RNA 下拉/质谱法所证明的那样。更重要的是,当 YTHDF3 而不是 YTHDF1/2 被击倒时,PRDX3 的表达被抑制。此外,PRDX3 翻译受 YTHDF3 以 m6A 依赖性方式直接调节,从而影响其在肝纤维化中的功能。总的来说,结果表明 PRDX3 是肝纤维化的关键调节因子,靶向 HSC 中的 YTHDF3/PRDX3 轴可能是一种有前途的肝纤维化治疗方法。此外,PRDX3 翻译受 YTHDF3 以 m6A 依赖性方式直接调节,从而影响其在肝纤维化中的功能。总的来说,结果表明 PRDX3 是肝纤维化的关键调节因子,靶向 HSC 中的 YTHDF3/PRDX3 轴可能是一种有前途的肝纤维化治疗方法。此外,PRDX3 翻译受 YTHDF3 以 m6A 依赖性方式直接调节,从而影响其在肝纤维化中的功能。总的来说,结果表明 PRDX3 是肝纤维化的关键调节因子,靶向 HSC 中的 YTHDF3/PRDX3 轴可能是一种有前途的肝纤维化治疗方法。

更新日期:2022-06-29
down
wechat
bug